Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA)

Sara Bringhen
First
;
Francesca Gay;Alessandra Larocca;Marco Salvini;Mario Boccadoro;
2018

103
9
1422
1432
https://haematologica.org/article/view/8581
https://doi.org/10.3324/haematol.2018.191288
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6119131/
Hematology
Sara Bringhen, Alberto Milan, Claudio Ferri, Ralph Wäsch, Francesca Gay, Alessandra Larocca, Marco Salvini, Evangelos Terpos, Hartmut Goldschmidt, Michele Cavo, Maria Teresa Petrucci, Heinz Ludwig, Holger W. Auner, Jo Caers, Martin Gramatzki, Mario Boccadoro, Hermann Einsele, Pieter Sonneveld, Monika Engelhardt
File in questo prodotto:
File Dimensione Formato  
Bringhen - CVAEs in Modern Myeloma Therapy - Haematologica 2018 - REVIEW.pdf

Accesso aperto

Descrizione: [Published vsn.] Bringhen S et al. Haematologica . 2018 Sep;103(9):1422-1432. doi: 10.3324/haematol.2018.191288. Epub 2018 Jul 26. ©2018 Ferrata Storti Foundation. Available at: https://haematologica.org/article/view/8581 | https://doi.org/10.3324/haematol.2018.191288 | http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6119131/
Tipo di file: PDF EDITORIALE
Dimensione 599.67 kB
Formato Adobe PDF
599.67 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1678687
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 44
social impact